98 related articles for article (PubMed ID: 8577054)
1. [I-cell disease and pseudo-Hurler polydystrophy].
Owada M
Nihon Rinsho; 1995 Dec; 53(12):3028-34. PubMed ID: 8577054
[TBL] [Abstract][Full Text] [Related]
2. Fibroblasts from patients with I-cell disease and pseudo-Hurler polydystrophy are deficient in uridine 5'-diphosphate-N-acetylglucosamine: glycoprotein N-acetylglucosaminylphosphotransferase activity.
Reitman ML; Varki A; Kornfeld S
J Clin Invest; 1981 May; 67(5):1574-9. PubMed ID: 6262380
[TBL] [Abstract][Full Text] [Related]
3. Plasma hyaluronidase activity in mucolipidoses II and III: marked differences from other lysosomal enzymes.
Natowicz MR; Wang Y
Am J Med Genet; 1996 Oct; 65(3):209-12. PubMed ID: 9240745
[TBL] [Abstract][Full Text] [Related]
4. Identification of a variant of mucolipidosis III (pseudo-Hurler polydystrophy): a catalytically active N-acetylglucosaminylphosphotransferase that fails to phosphorylate lysosomal enzymes.
Varki AP; Reitman ML; Kornfeld S
Proc Natl Acad Sci U S A; 1981 Dec; 78(12):7773-7. PubMed ID: 6461005
[TBL] [Abstract][Full Text] [Related]
5. [Disorders of phosphorylation system of lysosomal enzymes [mucolipidosis II, III]].
Owada M
Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):469-73. PubMed ID: 9645113
[No Abstract] [Full Text] [Related]
6. Correction of mucolipidosis III in vitro by gene transfer.
Fowler ML; Fan YS; Mueller OT; Henry WM; Shows TB
Genomics; 1993 Nov; 18(2):236-43. PubMed ID: 8288225
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of mouse GlcNAc-1-phosphotransferase-gamma subunit in cells induced an I-cell-like phenotype of mucolipidosis.
Sun Q; Li J; Wang C; Huang X; Huang H; Du D; Liang Y; Han H
Gene; 2005 Feb; 347(1):55-64. PubMed ID: 15716021
[TBL] [Abstract][Full Text] [Related]
8. Mucolipidosis II (I-cell disease) and mucolipidosis IIIA (classical pseudo-hurler polydystrophy) are caused by mutations in the GlcNAc-phosphotransferase alpha / beta -subunits precursor gene.
Kudo M; Brem MS; Canfield WM
Am J Hum Genet; 2006 Mar; 78(3):451-63. PubMed ID: 16465621
[TBL] [Abstract][Full Text] [Related]
9. Lysosomal phospholipase activity is decreased in mucolipidosis II and III fibroblasts.
Jansen SM; Groener JE; Poorthuis BJ
Biochim Biophys Acta; 1999 Jan; 1436(3):363-9. PubMed ID: 9989267
[TBL] [Abstract][Full Text] [Related]
10. Mucolipidosis II and III. The genetic relationships between two disorders of lysosomal enzyme biosynthesis.
Mueller OT; Honey NK; Little LE; Miller AL; Shows TB
J Clin Invest; 1983 Sep; 72(3):1016-23. PubMed ID: 6309902
[TBL] [Abstract][Full Text] [Related]
11. [Lysosomal hydrolases have specific conformational domains for acquisition of mannose-6-phosphate].
Himeno M; Tanaka Y
Nihon Rinsho; 1995 Dec; 53(12):2892-7. PubMed ID: 8577031
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the mutant N-acetylglucosaminylphosphotransferase in I-cell disease and pseudo-Hurler polydystrophy: complementation analysis and kinetic studies.
Ben-Yoseph Y; Pack BA; Mitchell DA; Elwell DG; Potier M; Melançon SB; Nadler HL
Enzyme; 1986; 35(2):106-16. PubMed ID: 3017692
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis of variant pseudo-hurler polydystrophy (mucolipidosis IIIC).
Raas-Rothschild A; Cormier-Daire V; Bao M; Genin E; Salomon R; Brewer K; Zeigler M; Mandel H; Toth S; Roe B; Munnich A; Canfield WM
J Clin Invest; 2000 Mar; 105(5):673-81. PubMed ID: 10712439
[TBL] [Abstract][Full Text] [Related]
14. A novel mutation in UDP-N-acetylglucosamine-1-phosphotransferase gamma subunit (GNPTAG) in two siblings with mucolipidosis type III alters a used glycosylation site.
Tiede S; Cantz M; Raas-Rothschild A; Muschol N; Bürger F; Ullrich K; Braulke T
Hum Mutat; 2004 Dec; 24(6):535. PubMed ID: 15532026
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of the GNPTAB and GNPTG genes in 13 patients with mucolipidosis type II or type III - identification of eight novel mutations.
Encarnação M; Lacerda L; Costa R; Prata MJ; Coutinho MF; Ribeiro H; Lopes L; Pineda M; Ignatius J; Galvez H; Mustonen A; Vieira P; Lima MR; Alves S
Clin Genet; 2009 Jul; 76(1):76-84. PubMed ID: 19659762
[TBL] [Abstract][Full Text] [Related]
16. Steps in the phosphorylation of the high mannose oligosaccharides of lysosomal enzymes.
Kornfeld S; Reitman ML; Varki A; Goldberg D; Gabel CA
Ciba Found Symp; 1982; (92):138-56. PubMed ID: 6295719
[TBL] [Abstract][Full Text] [Related]
17. Altered molecular size of N-acetylglucosamine 1-phosphotransferase in I-cell disease and pseudo-Hurler polydystrophy.
Ben-Yoseph Y; Potier M; Mitchell DA; Pack BA; Melançon SB; Nadler HL
Biochem J; 1987 Dec; 248(3):697-701. PubMed ID: 2829837
[TBL] [Abstract][Full Text] [Related]
18. Targeting of lysosomal enzymes: N-acetylglucosamine-1-phosphotransferase during muscle development.
Den H; Shanske S; DiMauro S
Muscle Nerve; 1986; 9(3):261-4. PubMed ID: 3010102
[TBL] [Abstract][Full Text] [Related]
19. Lysosomal enzyme phosphorylation in human fibroblasts. Kinetic parameters offer a biochemical rationale for two distinct defects in the uridine diphospho-N-acetylglucosamine:lysosomal enzyme precursor N-acetylglucosamine-1-phosphotransferase.
Lang L; Takahashi T; Tang J; Kornfeld S
J Clin Invest; 1985 Dec; 76(6):2191-5. PubMed ID: 3001146
[TBL] [Abstract][Full Text] [Related]
20. Demonstration of the heterozygous state for I-cell disease and pseudo-Hurler polydystrophy by assay of N-acetylglucosaminylphosphotransferase in white blood cells and fibroblasts.
Varki A; Reitman ML; Vannier A; Kornfeld S; Grubb JH; Sly WS
Am J Hum Genet; 1982 Sep; 34(5):717-29. PubMed ID: 6289658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
